Problems in the management of solitary nodules and diffuse goitres
A John Webb ChM FRCS FIAC SECTIONS OF ENDOCRINOLOGY, PATHOLOGY AND SURGERY For diffuse goitres and solitary or dominant thyroid nodules an enduring difficulty is the relative lack of diagnostic precision, particularly in clinical examination. The ease with which a goitre lies unnoticed or, if detected, is neglected or inappropriately investigated leads to a significant delay in the diagnosis of thyroid malignancy. Thyroid nodules are detectable in 40/o-10% of the general population, more so in some areas, but thyroid cancer is rare. It affects 2.0/ 100000 women and 0.5 /100000 men. It is generally accepted that 600/o-70% of cancers bear the clinical presentation of benignity so the problem is to detect occasional malignancy amongst a vast majority of benign nodules1.
Prompt recognition of thyroid abnormality and precise diagnosis is all important. Within a comprehensive investigation schedule, which must include serum thyroid function and antibody status, chest and thoracic inlet imaging, there is controversy as to the relative value of scintiscanning, ultrasound and magnetic resonance imaging/ computerized tomography (MRI/CT) scanning2 3.
The increasing adoption and acceptance of fine needle aspiration cytology (FNAC) adds an important dimension to diagnosis". Although this simple technique attracts both rejection and scepticism, there is a widespread view that, despite some deficiencies, it presents the most precise form of diagnosis currently available.
In expert hands, FNAC is cost effective and sensitivity rates for the discovery of neoplasm lie between 90% and 95% with a corresponding specificity of 95% to 99%, implying that false positive diagnoses are rare7. FNAC is invaluable to prevent crass clinical error and, prospectively, to direct surgical and medical management. However, its limits and difficulties should not be underestimated or override other modes of investigation. Thyroid smears can be a testing field in clinical cytology.
The definitive aims of FNAC may be summarized as follows:
* The confirmation of nodular colloid goitre in solitary, dominant or multinodular form where a pressing indication for surgery does not exist and a trial of Lthyroxine (T4) is worthwhile. In such patients, repeat FNAC is a sensible precaution. Also a large goitre, in a patient where there is a strong medical contraindication to surgery, can be monitored by FNAC * The recognition of both classical and atypical chronic lymphocytic thyroiditis (CLT) for which an adequate trial of T4 therapy is correct while at the same time identifying areas of Huirthle cell (HC) atypia. To confirm the clinical diagnosis of viral or granulomatous thyroiditis (De Quervain) * The identification of neoplasia; probable malignancy and the classification, where possible, of tumour type * The elucidation of problematical solitary cytic or mixed cystic and solid lesions by selecting out those which might be neoplastic * For easy and expeditious recognition of anaplastic carcinoma and non-Hodgkin's lymphoma wherein surgical intervention should be approached with caution, depending upon additional imaging evidence * The recognition of thyroid malignancy at metastatic sites; namely soft tissue masses, lymph nodes, osseous, hepatic and pulmonary deposits.
Since 1967, the author has incorporated clinical cytology and FNAC in particular into surgical diagnosis; goitres comprise an important group8. In most instances, the FNAC report was used prospectively, but since 1986 the investigation protocol has been tightened and a firm cytological diagnosis documented in the patient's records. For many patients this was a pre-operative report and the operation based on the findings. Problem areas appeared within a year of starting and over the years errors have been subject to careful scrutiny and results reported. Recently, a personal consecutive series of 117 patients assembled from the 3-year span (1990-1992) has been analysed in detail. These patients, most of whom were from consulting practice, were investigated, operated upon and followed by the author.
Surgery was performed in 93 and the remaining 24 are under regular clinical follow-up. Of 246 cytological examinations, some 182 FNAC procedures were associated with a low failed aspiration or inadequate sample rate of 0.5%. From the total of 39 neoplasms there were 15 malignancies (14 carcinomas and 1 lymphoma). FNA sensitivity for the detection of neoplasm as such was 38/39 (97%) and for malignancy 84%. The positive predictive value was 93%. The confirmation of benignity, i.e. specificity, lay at 99/100 (99%) but this group included 38% of atypical and, hence, difficult smears. The negative predictive value was 97%.
From this series, errors have been audited and analysed. The specific areas of difficulty previously experienced have been confirmed. They have been obvious since 1967 and are: These various headings will now be elaborated.
TECHNIQUE
The rate of failed or inadequate smears is commonly reported around 10% to 15% but may reach 25% to 30%13,14.
This renders FNAC frustrating and uneconomic. To lessen the incidence and ensure a failure rate of around 1% the following advice may be helpful: * A 2OmL syringe coupled with a 21, 23 or 25 gauge needle and used with constant suction is simple and adequate * The situation of a goitre may test aspiration technique.
The patient should be supine and with slight head end elevation and neck extension. It is possible to aspirate both anteriorly through the strap muscles and laterally through sternomastoid and from different angles. For a sizeable (50 g) goitre, more than one site should be aspirated * With a bloody or cystic yield, place the material on a slide and gently incline it to decant off the fluid. Solid fragments of tissue will settle on the slide. These can be spread with a needle point or slide edge. This is a simple and very effective trick * If the goitre is very vascular, puncture the gland with a 21 gauge (green) needle and allow blood-stained material to fill the needle shaft and hub. Remove it and blow out the contents, spreading the yield in the usual manner. This is goitre puncture without aspiration. It lessens the dilution of cellular material by blood and can be highly effective.
NODULAR GOITRE
By its very nature, nodular goitre comprises a varied pathological lesion. For the cytologist the standard appearances showing bland follicular epithelium, colloid and degenerative macrophages are simple to interpret. However, areas of hyperplasia are problematical and the nuclear enlargement and anisonucleosis is difficult to distinguish from a follicular lesion. Mostly the nuclear chromatin is regular and without nucleoli. Cystic nodular goitres may yield sheets of large atypical cells with big ovoid nuclei and profuse 'spindle type' cytoplasm. The appearances may be extravagant but are associated with plenty of otherwise benign follicular cells and colloid. The source of these atypical cells is a mystery but some may derive from squamoid metaplasia of the lining of cystic spaces. The term 'endotheliod' is perhaps appropriate'5.
PAPILLARY CARCINOMA Cystic change in both primary tumours and metastatic nodes is an interesting biological phenomenon but it provides a cytological problem. For nodes, however, assuming the clinical information is precise, any aspiration smear showing a resemblance to thyroid macrophage and epithelium, however bland and innocent they may appear, indicates metastatic cystic papillary cancer. For a primary tumour it is more difficult. Cystic adenomas and cystic hyperplastic nodules may yield fluid, colloid and thyroid macrophages. A helpful clue is to look closely at the profusion and nuclear size of the macrophages. For carcinoma there are many more macrophages and the nuclei are larger than normal. This is merely a reflection of the fact that in papillary carcinoma there is nuclear enlargement.
A detailed analysis of histological pattern and cell type in papillary cancer has been published'6, but there is disagreement as to the significance of degrees of differentiation. Cytologically, it is possible to identify examples of de-differentiated, often Hiirthle cell (HC) type, The conventional histopathological view is that histology alone can differentiate follicular adenoma from carcinoma. This means that for any possible follicular neoplasm, unilateral lobectomy is performed. Should histopathology identify carcinoma, then a second operation may be necessary.
Here surgical practice differs. If the lesion is microinvasive or minimally invasive at the capsule and not invading blood vessels, there is a tendency to prescribe Lthyroxine (T4) and maintain complete thyroid stimulating hormone suppression. For capsular macro-invasion and vascular involvement, further surgery and adequate local clearance is obligatory to permit 1 131 manipulation. If the biological malignant potential between micro-and macroinvasion is minimal, then total thyroidectomy as a single operation is an attractive operation long term. The operative risks and economic disadvantages of second procedures are significant. FNAC may help in selection.
A personal series reported in 198618 examined 35 follicular neoplasms; 37 adenomas and 16 carcinomas. The cytological sensitivity for detecting neoplasm was 90% and the sensitivities for adenoma and carcinoma were 86% and 81% respectively. By the strictest criteria and without any permanent morbidity, only three of the 53 received inappropriate surgery. However, there is no doubt that the cytological separation between adenoma and carcinoma is difficult in 150/o-20% of neoplasms19.
The status of HC lesions is even more taxing. Malignant HC tumours do not respond to T4 suppression, I 131 therapy or external irradiation. Hence, there should be a firm, surgical policy to obtain adequate local clearance at one operation. Any tumour shown cytologically to be a malignant or atypical HC should be treated by total thyroidectomy.
The atypical or hypercellular adenoma20 displays malignant cytology within the lesion but no, or uncertain, invasive features. We do not yet know if lobectomy is adequate treatment. By flow cytometry (DNA analysis)21 it is suggested that the biological malignant potential of histologically designated adenomas and carcinomas is blurred. This difficulty in separation is certainly reflected in cytological smears. At present, there is no substantial plan for the management of atypical adenoma. The ability to perform a complication-free total thyroidectomy is perhaps the best long-term guarantee for both patient and surgeon.
It is possible that, as in ovarian neoplasms, the entity of a borderline thyroid follicular tumour will become accepted.
CHRONIC LYMPHOCYTIC THYROIDITIS (CLT)
For the classical presentation of CLT as Hashimoto's disease by a diffuse, firm, bosselated goitre, diagnosis by FNAC coupled with positive serology is virtually 100% sensitive. For these, a trial of T4 therapy to produce thyroid stimulation hormone suppression (proven by measurement) is clearly indicated. If the goitre shrinks to a firm gland of natural or diminished proportions, then surgery is unnecessary. However, most presentations of CLT are atypical, appearing as a solitary nodule simulating neoplasm, a dominant nodule within a firm nodular goitre or as a sudden enlargement of a pre-existing nodular gland.
For all suspected examples of CLT, imaging ultrasound is helpful to outline distinct nodules and areas of suspicion.
Accepting that cytological smears from CLT vary in pattern of cell distribution and that HC or Askanazy cell appearances may be very florid, standard limits must be learned from experience. However, gross atypia may be seen. In addition, many examples of atypical CLT show negative serum antibodies. To separate atypical HC hyperplasia from neoplasm by cytology can be virtually impossible. Here, adequate local surgery is imperative and this often means total thyroidectomy. In the author's personal series (1990) (1991) (1992) , from 15 carcinomas, five (33%) were associated with well established CLT. It is possible that in some patients with CLT, especially the atypical form, epithelial instability is induced. Thyroid non-Hodgkin lymphoma is a rare entity but, in the author's experience, these patients when studied by cytology and histology have demonstrated a co-existing CLT.
It is evident that, for the diagnosis of all types of goitre, FNAC is imperfect, but it remains the most precise and economic investigation, being significantly superior to scintiscanning, ultrasound and CT/MRI scanning.
It is desirable from every point of view that unnecessary diagnostic and inadequate therapeutic thyroidectomies are avoided. Cytology can help to achieve this aim and FNAC needs to be further propagated, researched and refined to achieve these aims.
